Bloodstream Infections in Febrile Neutropenic Children with Cancer  by Hikawa, Renato et al.
S36 Infections in Cancer Patients and in Patients with Hematological Malignancies
84
Bloodstream Infections in Febrile Neutropenic Children
with Cancer
Renato Hikawa, A. Sérgio Petrilli, Janaina Goto,
Fabianne Carlesse, Maria Aparecida Aguiar, Alexandre Marra,
Carlos Alberto Pereira. Pediatric Department and Infectious
Disease Department, Pediatric Oncology Institute, Federal
University of São Paulo, São Paulo, Brazil
Background: The treatment of febrile neutropenia is an emergency
which is based on each Institution' s epidemiology.
Objective: To evaluate clinical and epidemiologic features of
bloodstream infections (BSI) and sensibility profile of main agents
and identifies risk factors related mortality.
Methods: All positive blood cultures from January 1st 2004 to 31st
December 2006 were evaluated retrospectively. Patients with can-
cer submitted to chemotherapy, younger than 21, with absolute
neutrophil (<500 cell/mm3) and fever were included. Patients sub-
mitted to bone marrow transplant and fever related to transfusion
reaction, were excluded. Statistical analysis was done by SPSS pro-
gram; p<0.05 was considered significant.
Results: Four hundred and two BSI were reported but only 153
episodes were analyzed; 55% were male, 76% were >3 years,
20% were in CTI, 57% had a CVC and 17% were submitted to
surgery. 95.6% were represented by bacteria, 4.4% were fungi.
Gram-negative rods caused 54.3%. Most common agents were:
Gram-negative E. coli (37%), K. pneumonie (15%) and Acineto-
bacter spp. (14%) and Gram-positive cocci were Coagulase Neg-
ative Staphylococci (40%), S. aureus (19%) S. viridans (17%). 77%
of Coagulase Negative Staphylococci were resistant to oxacilin
and 67% to clindamycin. All S. aureus were sensibly to oxacilin.
K. pneumoniae presented high resistant levels to cephalosporins
(38% to ceftriaxone, 43% to ceftazidime and 36% to cefepime)
and 43% were ESBL. Gram-negative rods (95 episodes) were ana-
lyzed together and were observed low resistance to polymyxinB
(0%) and to piperacillin/tazobactam (3%) against high resistance to
cephalosporins (17% to cefepime, 19% to ceftazidime and 22% to
ceftriaxone). The overall mortality rate within 30 days from the
first positive blood culture was 12.4%. Multivariate logistic regres-
sion demonstrated that presence of organic dysfunction (severe
sepsis and septic shock) and inappropriate initial antibiotic therapy
were independently associated to mortality (OR 9.42 and 11.46, re-
spectively).
Conclusions: Gram-negative bacteria presented high resistance to
antibiotics commonly used in our institution. The presence of or-
ganic dysfunction and inappropriate initial antibiotic therapy were
associated to mortality. Results confirm the importance of knowing
local epidemiology for the best treatment then reducing mortal-
ity.
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Background: Clostridium difficile infection (CDI) was considered a
mild nosocomial disease associated almost exclusively with the use
of antibiotics, but its epidemiology has changed dramatically.
Since 2002, outbreaks of severe CDI with a new strain BI/NAP1/027
have emerged and were associated with increased mortality and
reduced effectiveness of standard therapy. However, there is lack
of data about the epidemiology of this new virulent strain in cancer
centers.
Objective: To describe an outbreak of C. difficile BI/NAP 1/027
strain and the impact of multifaceted infection control measures.
Methods:We implemented in past years an active surveillance pro-
gram for CDI that allows us to collect and review the microbiology
records of all patients with positive C. difficile toxin in stools. As
part of this active surveillance, an outbreak was identified in May
of 2007. C. difficile isolates were cultured on cyloserine-cefoxitin-
fructose agar and polymerase chain reaction (PCR) was used to
identify the presence of binary toxin, a marker of the BI/NAP1/027
strain.
Results: During 2007, there were 321 cases of CDI with an average
rate of 0.86/1000 patient-days. Since March of 2007, we evidenced
an increase in the rate of CDI from 0.38 in February to 0.72 in March
with a peak rate of 1.92 in May of 2007 (p<0.05). An outbreak
team was convened and an action plan was developed. Mainly, ed-
ucation measures were implemented on floors and new signs were
placed on isolation carts reinforcing hand hygiene procedures with
the use of water of soap, environmental cleaning with 10% bleach,
and reinforcing the use of personnel protective equipment. As a
result, the rate of CDI decreased progressively to 0.44 in Novem-
ber 2007. Three clusters of patients with CDI, in different location
each, were identified during the outbreak necessitating additional
education and environmental cleaning in the affected areas. Since
May 2007, we were able to isolate 25 C. difficile strains from pa-
tients with CDI. Moreover, we have also confirmed for the first time
in our Institution the presence of C. difficile BI/NAP 1/027 binary
toxin in 6 cases.
Conclusion: We were able to confirm the change in the epidemi-
ology of CDI in our institution with the development of an out-
break secondary to the emergence of the new hypervirulent strain
BI/NAP1/027. Infection control measures were the cornerstone to
control this outbreak in this immunocompromised population.
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Background: Pyomyositis is an acute bacterial infection of the
skeletal muscle typically caused by Staphylococcus aureus. Few
cases have been described of Escherichia coli pyomyositis and the
associated virulence factors have not been studied.
Objective: To describe the clinical features, the phylogeny and the
virulence factors of E. coli pyomyositis.
Methods: After reviewing the microbiology database and medical
records of all E. coli isolated in our institution (2003–2007), six
cases of E. coli pyomyositis were identified. Clinical characteris-
tics of the disease, laboratory and radiologic findings, treatment
and outcome information were collected. Phylogeny and fifty-one
virulence factors of the isolates were analyzed using PCR.
Results: The mean age was 53 years old with a 1:2 female/male
ratio. All cases had a hematologic malignancy, were receiving
